Synthetic Cannabinoids: Effects, Risks, and Drug Testing
Synthetic cannabinoids are human-made chemicals designed to interact with cannabinoid receptors in the brain and body. Often sold under names such as K2, Spice, and synthetic marijuana, these substances can produce effects similar to cannabis but may cause more severe and unpredictable reactions.
Unlike natural cannabis, synthetic cannabinoid products can contain different chemicals, varying concentrations, and undisclosed additives. Their composition may change between batches, making it difficult to predict their effects or identify them through routine drug screening.
Understanding synthetic cannabinoids, their potential health effects, and the limitations of standard drug tests is important for healthcare professionals, employers, attorneys, investigators, and individuals seeking specialized toxicology testing.
What Are Synthetic Cannabinoids? (Examples and Definition)
Synthetic cannabinoids are laboratory-created compounds that interact with the body’s cannabinoid receptors. Although some are designed to produce effects similar to THC, the primary psychoactive compound in cannabis, their chemical structures and biological activity can differ considerably.
These substances are sometimes marketed as synthetic marijuana, fake weed, herbal incense, or liquid incense. Products may consist of dried plant material treated with synthetic chemicals or liquids containing these compounds.
One historical example is JWH-018, a synthetic cannabinoid originally developed for scientific research. Compounds from the JWH family have also been identified in illicit products sold as K2 or Spice.
The name on a package does not reliably identify its chemical contents. Laboratory analysis may be necessary to determine which compounds are present in a sample.
Why Are Synthetic Cannabinoids More Dangerous Than Natural Cannabis?
Synthetic cannabinoids can produce stronger and less predictable effects than natural cannabis. Many compounds act as full agonists at CB1 cannabinoid receptors, potentially activating these receptors more intensely than THC, which is a partial agonist.
The actual effects depend on the particular chemical, the amount and route of exposure, and whether other substances are present. Illicit products may contain uneven concentrations of active ingredients or multiple compounds, increasing the uncertainty surrounding their effects.
Potential complications include:
- Neurological effects: Confusion, agitation, seizures, and reduced consciousness.
- Psychological effects: Severe anxiety, paranoia, hallucinations, and psychosis.
- Cardiovascular effects: Rapid heartbeat, elevated blood pressure, chest pain, and heart complications.
- Other physical effects: Severe vomiting, kidney injury, and muscle damage.
Synthetic cannabinoids should not be considered a safe alternative to cannabis. Severe poisoning can occur, and some reactions may be life-threatening.
Common Myths vs. Reality
Misleading product labels can create a false impression that synthetic cannabinoids are natural, harmless, or suitable for consumption. Understanding the difference between marketing claims and actual risks is essential.
- Myth: Synthetic cannabinoid products are natural because they contain dried plants.
- Reality: The plant material may be treated with laboratory-created chemicals that cause the psychoactive effects.
- Myth: Synthetic marijuana is always safer than natural cannabis.
- Reality: Synthetic cannabinoids can cause serious and unpredictable health complications.
- Myth: Products labeled “not for human consumption” are safe to handle or use.
- Reality: Such labels do not establish safety, purity, or suitability for any particular use.
Product appearance, packaging, and marketing claims cannot reliably establish chemical composition or safety.
Common Synthetic Cannabinoid Names and List
Synthetic cannabinoid products are sold under different brand names, while the chemicals used in their formulations can change over time. A product name alone cannot confirm which compound it contains.
Street Brands and Products
Names historically associated with products containing synthetic cannabinoids include:
- K2 and Spice: Widely recognized names associated with synthetic cannabinoid products.
- Genie and Yucatan Fire: Names reported in connection with products sold in this category.
- Skunk, Scope, and Sky: Names that have been associated with certain marketed formulations.
- Moon Rocks and Solar Flare: Names reported for some products in this category.
- Galaxy Gold and Space Truckin: Other names associated with synthetic cannabinoid products.
This is an illustrative list, not a verified inventory of current products. Formulations may vary, and the same name does not guarantee the same ingredients across products or batches.
Technical Synthetic Cannabinoid Compounds
Laboratory testing focuses on identifying specific compounds or their metabolites rather than relying solely on product names. Synthetic cannabinoids include multiple chemical families, and new analogues may emerge over time.
Examples of compounds historically studied or identified in synthetic cannabinoid research include:
- JWH series: JWH-018, JWH-073, JWH-081, JWH-200, and JWH-250.
- CP series: CP 47,497 and related research compounds.
- Other synthetic cannabinoid compounds: WIN 55,212-2 and selected newer or emerging analogues, depending on the laboratory’s validated testing scope.
The compounds included in a particular test panel depend on the laboratory’s method and the analytes it has validated. Confirm the exact panel composition with the laboratory before relying on a test to identify a specific substance.
Side Effects of Synthetic Cannabinoids
Synthetic cannabinoid effects can range from temporary discomfort to severe poisoning. Because the chemical composition and concentration of these products may be unknown, the response can differ substantially between individuals and exposures.
Common Physical and Psychological Effects
- Anxiety and agitation: Intense fear, restlessness, or panic.
- Confusion and altered perception: Difficulty concentrating, disorientation, or hallucinations.
- Rapid heart rate: An increased heart rate and potentially elevated blood pressure.
- Nausea and vomiting: Gastrointestinal symptoms that may become severe.
- Seizures: Serious neurological reactions that require immediate medical attention.
- Severe complications: In some cases, exposure can be associated with kidney injury, breathing difficulties, or cardiovascular emergencies.
The severity and duration of symptoms depend on the substance involved, the amount and route of exposure, and individual factors.
Synthetic Cannabinoid Drug Testing and Laboratory Detection
Routine workplace drug screens may not detect synthetic cannabinoids because many standard panels are designed to identify specific drugs or their metabolites, rather than the wide range of synthetic cannabinoid compounds.
A standard five-panel or ten-panel drug screen should not be assumed to detect K2, Spice, or every synthetic cannabinoid. Detection depends on the compounds targeted by the test and the analytical method used.
Specialized toxicology testing may use techniques such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) or gas chromatography-mass spectrometry (GC-MS), where appropriate, to identify targeted compounds or metabolites. The suitability of each method depends on the analytes and the laboratory’s validated procedure.
Our Synthetic Cannabinoid 16-Panel Testing Capabilities
The Carlson Company offers specialized synthetic cannabinoid testing intended to screen for multiple targeted compounds associated with synthetic cannabinoid exposure.
Depending on the specific test and laboratory requirements, sample types may include:
- Urine specimens: May be analyzed for targeted metabolites that indicate prior exposure.
- Blood samples: May be appropriate when investigating recent exposure, depending on the substance and testing method.
- Hair samples: May provide a longer-term testing window for certain substances, subject to sample suitability and the laboratory’s validated method.
The appropriate specimen depends on the purpose of testing, the suspected timing of exposure, and the compounds being investigated.
| Sample Type | General Testing Considerations |
| Blood | May be useful for investigating recent exposure, depending on the compound and circumstances. |
| Urine | Often used to test for targeted drug metabolites following exposure. |
| Hair | May help investigate exposure over a longer period when the substance and method are suitable. |
Detection windows are not fixed. They vary with the specific compound, metabolite, amount and frequency of exposure, specimen characteristics, and analytical method. A laboratory should confirm the expected detection window for the test being considered.
No test panel can guarantee detection of every synthetic cannabinoid. New compounds may not be included in an existing panel, and a negative result does not necessarily rule out exposure to an untested substance.
For information about the available testing scope, sample requirements, and appropriate laboratory methods, contact The Carlson Company.
Is the Use of Synthetic Cannabinoids Legal?
The legal status of synthetic cannabinoids in the United States depends on the specific compound, applicable federal and state laws, and the circumstances of possession, distribution, or intended use.
Many synthetic cannabinoid substances are controlled under federal law or state-specific legislation. Certain substances may also fall within broader legal provisions addressing chemically related compounds or analogues.
Because chemical formulations and applicable laws can change, the legality of a product should not be determined solely by its brand name, packaging, or marketing claims. A label such as “herbal incense” or “not for human consumption” does not establish that the product is legal.
For a specific legal question, consult current Drug Enforcement Administration (DEA) information, applicable state law, or a qualified legal professional.
Forensic Toxicology and Analytical Considerations
Synthetic cannabinoid investigations can present analytical challenges because the compounds used in products may change rapidly. Routine drug screening may not include the specific substances involved, and the presence of an unfamiliar compound can complicate interpretation.
A reliable toxicology investigation considers several factors:
- Test selection: The method should target compounds or metabolites relevant to the investigation.
- Specimen suitability: Sample type, collection timing, storage, and condition can influence whether analysis is possible.
- Analytical limitations: A test can identify only the substances or markers within its validated scope and detection capabilities.
- Result interpretation: Findings should be interpreted in the context of the sample, analytical method, and circumstances of the case.
- Chain of custody: When results are intended for legal or investigative use, documented sample handling and appropriate chain-of-custody procedures may be essential.
The Carlson Company provides specialized toxicology testing services for appropriate cases. Test selection should be based on the investigation’s objectives and the laboratory’s available methods.
Frequently Asked Questions (FAQs)
Q1: Can synthetic cannabinoids cause long-term health problems?
The long-term effects are not fully understood and may vary depending on the compound, frequency of exposure, and severity of any poisoning. Repeated use has been associated with dependence and withdrawal symptoms in some individuals. Anyone experiencing ongoing physical or psychological symptoms should consult a qualified healthcare professional.
Q2: Can a negative synthetic cannabinoid test rule out exposure?
No. A negative result means the test did not identify the targeted analytes at detectable levels under the conditions of that test. It cannot reliably exclude exposure to compounds that were not included in the panel or were outside the method’s detection capabilities.
Q3: What information should you provide when requesting synthetic cannabinoid testing?
Share the purpose of the test, the suspected timing of exposure, the available specimen type, and any known information about the suspected substance. For legal or forensic investigations, explain whether documented chain of custody and specific reporting requirements are needed. The laboratory can use this information to help determine which testing options may be appropriate.
Q4: How can you choose an appropriate synthetic cannabinoid test panel?
Review the panel’s target compounds, specimen requirements, analytical method, reporting limitations, and suitability for the intended purpose. Ask whether the suspected substance or its metabolites are included and whether the test is appropriate for clinical, workplace, or forensic use. A larger panel does not automatically guarantee detection of every synthetic cannabinoid.
